Immune Checkpoint Inhibitors’ Associated Renal Toxicity: A Series of 12 Cases

We present a series of twelve patients, bearing a wide range of solid malignancies, who received either PD-L1 or a combination of PD-L1 and CTLA-4 inhibitors. Following immunotherapy administration, they exhibited the clinical signs indicative of renal toxicity, including increased serum creatinine...

Descripción completa

Detalles Bibliográficos
Autores principales: Palamaris, Kostas, Alexandris, Dimitrios, Stylianou, Kostas, Giatras, Ioannis, Stofas, Anastasios, Kaitatzoglou, Christina, Migkou, Magda, Goutas, Dimitrios, Psimenou, Erasmia, Theodoropoulou, Eleni, Theocharis, Stamatios, Alevizopoulos, Nektarios, Kastritis, Efstathios, Gerakis, Alexandros, Gakiopoulou, Harikleia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409791/
https://www.ncbi.nlm.nih.gov/pubmed/36013025
http://dx.doi.org/10.3390/jcm11164786

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9409791/
https://www.ncbi.nlm.nih.gov/pubmed/36013025
http://dx.doi.org/10.3390/jcm11164786

Ejemplares similares